FindTrial
Sign In

Comparison between two different routes intranasal and intravenous of dexmedetomidine on hemodynamic changes during awake fiberoptic nasotracheal intubation

Comparison between intranasal and intravenous dexmedetomidine on hemodynamic responses, sedation and tolerance to intubation during awake fiberoptic nasotracheal intubation : A prospective randomized study

Status
Active, not recruiting
Phases
Unknown
Study type
Interventional
Source
CTRI
Registry ID
CTRI/2021/08/035318
Enrollment
80
Registered
2021-08-02
Start date
Unknown
Completion date
Unknown
Last updated
2021-11-24

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Health Condition 1: C148- Malignant neoplasm of overlappingsites of lip, oral cavity and pharynx

Interventions

Intervention1: In Group N patients will receive inj. Dexmedetomidine(1mcg/kg) intranasally 30 min before induction: 40 patients in Group N will receive inj. dexmedetomidine(1mcg/kg) through tuberculin

Sponsors

GCS medical college
Lead Sponsor

Eligibility

Inclusion criteria

Inclusion criteria: ASAPS 1 2 Predicted difficult intubation MPG 3 4 Elective surgery under general anesthesia

Exclusion criteria

Exclusion criteria: Nasal deformity polyp or trauma On anticoagulants Liver Kidney psychiatric diseases Refuse to give written informed consent on Beta blockers or on digoxin Pregnant or lactating women

Design outcomes

Primary

MeasureTime frame
intra op hemodynamic changesTimepoint: t1 t2 t3—

Secondary

MeasureTime frame
Patient tolerance to intubation scoreTimepoint: at time of intubation;sedation score during procedureTimepoint: t1 t2 t3—

Countries

India

Contacts

Public ContactDr Deepa Jadav

GCS medical college hospital & research centre

drdeepa0202@gmail.com7874145408

Outcome results

None listed

Source: CTRI (via WHO ICTRP) · Data processed: Feb 4, 2026